¼«Ôÿª»§Æ½Ì¨

English ¼«Ôÿª»§Æ½Ì¨¼¯ÍÅÆóÒµÓÊÏä

ÔÙÉúÒ½ÁƼ¼ÊõÅäºÏ΢Á£Æ¤ÅàÖ²ÐÞ¸´Æ¤·ôÂýÐÔÀ£Ññ´´ÃæµÄÁÙ´²·ÖÎö

2013Äê-11ÔÂ-25ÈÕ À´Ô´£º¼«Ôÿª»§Æ½Ì¨¹ú¼Ê¼¯ÍÅ

ÄÏ·½Ò½¿Æ´óѧÖÐҽҩѧԺ£¬ºÎÈÊÁÁ  Ñî¡¡Áø;  ÖÐɽÊÐ»ÆÆÔÈËÃñÒ½Ôº£¬ÓàÖ¾ºÍ£¬ÁõÓ¢Ï飬Àî·ï´º
  ¹ãÖÝÖÐÒ½Ò©´óѧÁ¥ÊôµÚ¶þÒ½Ôº£¬ÀîºìÒã

¡¾ÕªÒª¡¿¡¡Ä¿µÄ£ºÌ½ÌÖÔÙÉúÒ½ÁƼ¼ÊõÅäºÏ×ÔÌå΢Á£Æ¤ÅàÖ²±íƤ»¯ÔÚÆ¤·ôÂýÐÔÀ£Ññ´´ÃæÐÞ¸´ÖÎÁÆÖеÄÓ¦Óá£ÒªÁ죺ÏÈÀûÓÃÆ¤·ôÍâ¿Æ¼¼ÊõÇå³ý´´Ã滵ËÀ×éÖ¯ºó£¬ÀûÓÃʪÈóÉÕÉ˸àÅàÑøÈâÑ¿£¬È»ºó°´À£Ññ´´Ãæ£ºÈ¡Æ¤Ãæ»ý=20¡«30¡Ã1µÄ±ÈÀýÈ¡ÈͺñƤ¼ô³É΢Á£Æ¤Á£ºóÖÖÖ²ÓÚÈâÑ¿ÖУ¬ÔÙÓÃʪÈóÉÕÉ˸àÅàֲ΢Á£Æ¤Ö±ÖÁ±íƤ»¯ÐÞ¸´´´Ãæ¡£½á¹û£º2005Äê9ÔÂ~2007Äê9ÔÂÎÒÃÇÓÃ΢Á£Æ¤ÖÖÖ²ÊõÖÎÁÆ31ÀýƤ·ôÂýÐÔÀ£Ññ»¼Õß»ñµÃÂúÒâЧ¹û¡£½áÂÛ£ºÎ¢Á£Æ¤ÖÖÖ²Êõ½áºÏʪÈóÉÕÉ˸àÖÎÁÆÆ¤·ôÂýÐÔÀ£Ññ£¬ ÊÖÊõ²Ù×÷¼òµ¥£¬Êõºó¹©Æ¤ÇøÓúºÏºÃ£¬À£ÑñÇøÐÞ¸´ºóƤ·ôÈáÈí¡¢ñ£ºÛÉÙ¡¢¹¦Ð§Ó°ÏìС£»ÓÉÓÚÊÖÊõÈ¡Æ¤Ãæ»ýԶԶСÓÚ´´Ã棬΢Á£Æ¤Ö±½ÓÖÖÖ²ÓÚ´´ÃæÈâÑ¿ÄÚ£¬Êõºó¶Ô´´ÃæÊàŦ»î¶¯ÒªÇóÏà¶ÔµÍ£¬ËùÒÔ»¼ÕßÒÀ´ÓÐԺᣱ¾·¨È±µãÊDz¿ÃŲ¡ÀýÖÖÖ²µÄ΢Á£Æ¤³É»îÂʽϵÍ£¬Ðë¶à´ÎÖÖÖ²£¬ÐÞ¸´Ê±¼ä¿ÉÄܽϳ¤¡£
¡¾Òªº¦´Ê¡¿¡¡ÔÙÉúÒ½ÁƼ¼Êõ;Ƥ·ôÂýÐÔÀ£Ññ£»×ÔÌå΢Á£±íÆ¤ÒÆÖ²

Clinical Report of Repair of Chronic Skin Ulcers with Autografting Microparticle Skin£®HE Ren-liang1, YU Zhi-he2, LIU Ying-xiang2, et al£®1£®School of Traditional Medicine, Southern Medical University, Guangzhou City, Guangdong Province, 516000, China; 2£®Dept£®of Dermatology, the People's Hospital, Huangpu District, Zhongshan City, Guangdong Province, 528429, China£®
¡¾Abstract¡¿¡¡Objective: To explore the epidemic repair of chronic skin ulcers treating with autografting microparticle skin£®Method: After necrotic tissue removed at the wound with surgery method and granulation tissue cultured with MEBO, microparticle skin tablet prapared with split-thickness skin according to the proportion of 20~30:1 (Ulcer area : skin area) and then the skin tablets were cultivated at granulation with MEBO till epidemic repair completed£®Result: All 31 cases of chronic ulcer patients collected from Sep£® 2005 to Sep£®2007 were treated with microparticle skin tablets culture and  satisfactory effect was obtained£®Conclusion: Treating chronic ulcers with microparticle skin tablets autografting cultured by MEBO has advantages£¬such as simple operation, good repair effect for donate site wound; and soft skin, less scar formation and better joint function obtained at healed ulcer wound site£®Because the area of donor site was far less than that of ulcer wound and microparticle skin tablets were planted into granulation directly, little requirement for the joint function was required after surgery, so it is more acceptable by the patient£®But, there are some disadvantages including lower survival rate of microparticle skingrafting£®For some patients, multiple grafting and longer repair time are required sometime£®
¡¾Key words¡¿¡¡Chronic skin  ulcer; Auto-microparticle skingrafting; Plantation
ÓÉÓÚȱ·¦ÓÕµ¼±íƤÉú³¤·¢ÓýµÄ΢»·¾³£¬ÌåÍâÁ¢ÌåÅàÑøµÄ±íƤϸ°ûûÓеäÐÍµÄ±íÆ¤½á¹¹[1]£¬Òò´Ë²»ÄÜÓÐЧµØÐÞ¸´Æ¤·ô´´Ã档ʪÈóÉÕÉ˸ࣨ¼ò³ÆMEBO£©×÷Ϊ´´ÃæÐÞ¸´µÄÒ»ÖÖ¾ßÓÐ×ÔÖ÷֪ʶ²úȨµÄÖÐÒ©ÖÆ¼Á£¬²»½öÔÚԭλ¾ßÓиÉϸ°ûÅàÖ²×÷Óã¬ÔÚÌåÍâÒ²¾ßÓиÉϸ°ûÅàÖ²×÷ÓÃ[2]¡£ÎªÁËÊÓ²ì×ÔÌå΢Á£Æ¤ÖÖÖ²Êõ½áºÏMEBOÖÎÁÆÆ¤·ôÂýÐÔÀ£ÑñµÄÁÆÐ§£¬ÎÒÃÇÀûÓÃ×ÔÌå΢Á£Æ¤ÖÖÖ²Êõ½áºÏMEBO¶Ô31ÀýȱËðÔÚ5cm2ÒÔÉÏµÄÆ¤·ô´´Ãæ½øÐÐÐÞ¸´£¬²¢½øÐÐÈ«³ÌµÄÁÙ´²ÊӲ졣ÏÖ³ÂËßÈçÏ£º
1£®ÁÙ´²×ÊÁÏ
1£®1£®Ò»°ã×ÊÁÏ£ºÈ«²¿²¡Àý¾ùΪÎÒ¿Æ×¡Ôº²¡Àý£¬ÆäÖÐÄÐ18Àý£¬Å®13Àý£»×î´óÄêÁä78Ë꣬×îСÄêÁä19Ë꣬ƽ¾ùÄêÁä52.7Ëꣻ²¡³Ì×5Ä꣬×î¶Ì4¸öÔ£¬Æ½¾ù²¡³Ì9.6¸öÔ£»ÌÇÄò²¡ÐÔÆ¤·ôÀ£Ññ7Àý£¬´´ÉËÐÔÀ£Ññ5Àý£¬Ñ¹Á¦ÐÔÀ£Ññ6Àý£¬ °©ÐÔÀ£Ññ3Àý£¬ÉÕÉ˲ÐÓà´´ÃæÀ£Ññ5Àý£¬·ÅÉäÐÔÀ£Ññ2Àý£¬ÊÖÊõÇпÚÓúºÏ²»Á¼ÐÔÀ£Ññ3Àý£»À£ÑñÃæ»ý×îС2.3cm×2.8cm£¬×î´ó15cm×12cm£¬Æ½¾ù4cm×2.3cm¡£
1£®2£®Õï¶Ï³ß¶È£º²ÎÕÕÈì´¯ Wagner·Ö¼¶1~2¼¶½øÐÐÀ£Ññ·Ö¼¶¡£
1£®3£®ÈëÑ¡²¡Àý£ºÐķθÎÉö¹¦Ð§Á¼ºÃ£¬Æ¤·ôÀ£Ññ²¡³Ì1¸öÔÂÒÔÉÏ¡¢Ãæ»ý´óÓÚ5cm2Õß¡£
1£®4£®Åųý²¡Àý£º£¨1£©ÕýÔÚ½ÓÊÜÌÇÆ¤Öʼ¤ËØ¡¢ÃâÒßÒÖÖÆ¼Á¼°Ö×Áö»¯ÁÆÕß¡££¨2£©ÕýÔÚ½ÓÊÜ»ò¹ýÈ¥1 ¸öÔÂÄÚ½ÓÊܹýÉú³¤Òò×ÓÖÎÁÆÕß¡££¨3£©²îÒìÒâ½ÓÊÜ×ÔÌå΢Á£Æ¤ÖÖÖ²ÊÖÊõÕß¡££¨4£©À£Ññ´´ÃæÃæ»ý<5cm2Õß¡£
1£®5£®ÌÞ³ý²¡Àý£ºÒòÖÖÖÖÔ­ÒòÖÐ;Í˳ö»òδÍê³ÉÖÎÁƵϼÕß¡£
1£®6£®´´ÃæÆÀ¹À³ß¶È£º
1£®6£®1£®´´Ãæ·Ö¼¶¼°¼Ç·Ö£º1¼¶£ºÕæÆ¤È«²ãÊÜË𣬴©ÈëÆ¤ÏÂ×éÖ¯£¬µ«ÉÐδ´©Í¸½îĤ¼°¼¡Èâ²ã£»2¼¶£ºÈ«Æ¤²ãË𺦣¬´©Í¸½îĤ£¬Éî´ï¼¡Èâ²ã£» 3¼¶£ºÈ«Æ¤²ãË𺦣¬´©Í¸½îĤ¼°¼¡Èâ²ã£¬Éî´ï¹Ç÷À£¬Ö¹Ç÷ÀÍâ¶¡£
1£®6£®2£®ÉË¿ÚÆÀ¹À£º²ÎÕÕ¡¶ÊµÓÃÉ˿ڻ¤Àíѧ¡·ÉË¿ÚÆÀ¹À±íÖÆ¶¨ÈçÏ£º
£¨1£©À£ÑñÍâòɫÔó£º
4·Ö£ººìÈó£»
3·Ö£ºµ­ºìÉ«£»
2·Ö£º°µºìÉ«£»
1·Ö£º×ϰµ»ò²Ô°×É«¡£
£¨2£©ÉË¿ÚÉøÒºÁ¿£º
4·Ö£ººÜÉÙÁ¿£ºÉË¿ÚÍâòʪÈ󣬵«ÎÞ·¨ÕÉÁ¿³öÉøÒºÁ¿£¬»òûÓÐÉøÒº£»
3·Ö£ºÉÙÁ¿£ºÉË¿ÚÉø³öÒºÉÙ£¬Õ´ÊªÄÚ²ã·óÁÏ≤25£¥£»
2·Ö£ºÖÐÁ¿£ºÉø³öҺմʪÄÚ²ã·óÁÏ26%¡«75£¥£»
1·Ö£º´óÁ¿£ºÉø³öҺմʪÄÚ²ã·óÁÏ76%¡«100£¥¡£
£¨3£©ÐÂÉúÈâÑ¿×éÖ¯
    4·Ö£ºÐÂÏÊÈâÑ¿×éÖ¯ÔÚ´´ÃæÂþÑÜ≥76%£»
    3·Ö£ºÐÂÏÊÈâÑ¿×éÖ¯ÔÚ´´ÃæÂþÑÜ51%¡«75%£»
    2·Ö£ºÐÂÏÊÈâÑ¿×éÖ¯ÔÚ´´ÃæÂþÑÜ26%¡«50%£»
¡¡¡¡1·Ö£ºÐÂÏÊÈâÑ¿×éÖ¯ÔÚ´´ÃæÂþÑÜ≤25%¡£
£¨4£©ÐÂÉúÉÏÆ¤×éÖ¯
4·Ö£ºÐÂÉúÉÏÆ¤×éÖ¯ËùÁýÕÖ´´ÃæÃæ»ý≥76%£»
3·Ö£ºÐÂÉúÉÏÆ¤×éÖ¯ËùÁýÕÖ´´ÃæÃæ»ý51%¡«75%£»
2·Ö£ºÐÂÉúÉÏÆ¤×éÖ¯ËùÁýÕÖ´´ÃæÃæ»ý26%¡«50%£»
1·Ö£ºÐÂÉúÉÏÆ¤×éÖ¯ËùÁýÕÖ´´ÃæÃæ»ý≤25%¡£
1£®7£®ÖÎÁÆÒªÁ죺ËùÓÐÄÉÈëÕß½øÈëÑо¿Ê±¾ùÓèÒÔ¼û¸æ²¢Ç©ÊðÖªÇéͬÒâÊé¡£
1£®7£®1£®È«ÉíÖÎÁÆ£ºÁ½×鲡È˾ùʹÓ㺣¨1£©Õë¶ÔÔ­·¢²¡µÄÖÎÁưüÂÞ½µµÍѪÌÇ¡¢¼ÓÇ¿ÓªÑøÖ§³Ö¡¢¸ÄÉÆÎ¢Ñ­»·µÈ£»£¨2£©Æ¾¾Ý´´ÃæÏ¸¾ú¼°Õæ¾úÅàÑø¼°Ò©Ãô½á¹ûÑ¡ÔñÏàÓ¦µÄ¿¹¾úÖÎÁÆ¡£
1£®7£®2£®Î¢Á£Æ¤ÖÖÖ²Êõ£º£¨1£©´´ÃæÔÚÇå³ý½¹ð衢ŧðèÒÔ¼°»µËÀ×éÖ¯ºó£¬ÓÃMEBOÒ©É´ÁýÕÖ´´Ã棬¼õѹ°üÔú£¬Ã¿ÈÕ1´Î£¬ÅàÑøÐÂÏʵÄÈâÑ¿£¬»»Ò©Ê±¼ÈÒª×öµ½Î¢´´ÇåÀí»µËÀ×éÖ¯£¬ÓÖҪʹ´´ÃæÉÙÊܴ̼¤£¬ÉÙ³öѪ¡££¨2£©Î¢Á£Æ¤ÖÖÆ¤Ê±»ú£ºÉË¿ÚÉø³öÒºÉÙ£¬Õ´ÊªÄÚ²ã·óÁÏ≤25£¥£¬ÐÂÏÊÈâÑ¿×éÖ¯ÔÚ´´ÃæÂþÑÜ51%¡«75%ÒÔÉÏ£¬´´ÃæÆÀ·Ö8·ÖÒÔÉÏ¡££¨3£©Î¢Á£Æ¤ÖÆ×÷£ºÍ¨Àýѡȡ¹©Æ¤Çø£¬Ïû¶¾Âé×íºó£¬°´È¡Æ¤Ãæ»ý£º´´ÃæÃæ»ý=1£º20¡«30µÄ±ÈÀýÈ¡ÈͺñƤƬ£¬ÔÚÎÞ¾úÉúÀíÑÎË®Öмô³É0.1cm~0.2cm¾ÞϸµÄ΢Á£Æ¤¡££¨4£©Î¢Á£Æ¤ÖÖÖ²£ºÏÈͨÀýÏû¶¾´´Ã棬ÓÃÑÛ¿ÆÎÞ³ÝÄ÷½«Î¢Á£Æ¤ÖÖÖ²ÓÚ´´ÃæÈâÑ¿ÖУ¬¼ä¸ôÔ¼0.3cm~0.5cm£¬Éî¶ÈÔ¼0.2cm~0.3cm£¬ÎÞ¾úÉ´²¼Ñ¹ÆÈֹѪ£¬È»ºóÁýÕÖÒ»²ãMEBOÒ©É´£¬ÎÞ¾úÉ´²¼°üÔú£¬Ã¿Ìì»»Ò©1´Î¡£´ýƤµºÀ©´óÏ໥ÈںϺóÔÙ¾Ö²¿·À°Ì´¦Öá£
1£®7£®3£®ÊÓ²ìʱ¼ä£ºÊõºó28Ìì¡£
1£®8£®ÊÓ²ìÖ¸±ê£º
1£®8£®1£®´´ÃæÃæ»ý£ºÓÃ͸Ã÷·½¸ñÖ½£¬ÔÚ»¼ÕßÈëԺʱÕÉÁ¿´´ÃæµÄÃæ»ýΪ³õÊ¼Ãæ»ý£¬ÁƳ̽áÊøÊ±ÕÉÁ¿¸÷ʱÏàµãµÄÐÞ¸´Ãæ»ý¡£¼ÆË㹫ʽ£º´´ÃæÓúºÏÃæ»ý°Ù·Ö±È£½£¨ÓúºÏÃæ»ý£¯³õÊ¼Ãæ»ý£©×100£¥¡£½ÓÄÉAdobe ImageReady 7.0ºÍOsirisÈí¼þ¼ÆËã´´ÃæÃæ»ý¡£

 

¼«ÔÃ-¼«ÔÃ×¢²á(Æ½Ì¨ÍøÕ¾)

1£®8£®2£®´´ÃæÇé¿ö£ºÔÚÖÎÁÆÇ°ºóƾ¾Ý´´ÃæÆÀ¼Û³ß¶È¼Æ·Ö£¬ ²¢ÉãÓ°Áô´æÕÕÆ¬½øÐÐǰºó¶Ô±È¡£
1£®9£®ÖÎÁƽá¹û£º
1£®9£®1£®ÆÀ¼Û³ß¶È£º°´´´ÃæÆÀ¹À³ß¶È¼Æ·Ö×ܵ÷ֽøÐÐÆÀ¼Û£¬ÖÎÓú£º16·Ö£»ÓÐЧ12·Ö¡«15·Ö£»ÎÞЧ<12·Ö¡£
1£®9£®2£®ÁÙ´²ÊÓ²ì½á¹û£ºÖÎÁÆ4Öܺó×ÛºÏÆÀ·Ö16·ÖµÄ25Àý£¬15·ÖµÄ2Àý£¬12·Ö4Àý¡£ÖÎÁÆ8ÖܺóÖ»ÓÐ2Àý×Ü»ý·ÖΪ12·Ö£»ÖÎÁÆ12ÖܺóÈ«²¿²¡Àý»ý·Ö¾ù´ï15·ÖÒÔÉÏ¡£
2£®½áÂÛ
4ÖÜÊÓ²ìÆÚÖÎÓú25Àý£¬ÁÆÐ§Á¼ºÃ6Àý¡£Î¢Á£Æ¤ÖÖÖ²Êõ½áºÏƤ·ôԭλÔÙÉú¼¼ÊõÖÎÁÆÆ¤·ôÂýÐÔÀ£Ññ£¬ ÊÖÊõ²Ù×÷¼òµ¥£¬Êõºó¹©Æ¤ÇøÓúºÏºÃ£¬À£ÑñÇøÐÞ¸´ºóñ£ºÛÉÙÇÒÈáÈí£¬¹¦Ð§Ó°ÏìС£»ÓÉÓÚÊÖÊõÈ¡Æ¤Ãæ»ýԶԶСÓÚ´´Ã棬΢Á£Æ¤Ö±½ÓÖÖÖ²ÓÚ´´ÃæÈâÑ¿ÄÚ£¬Êõºó¶ÔÏÞÖÆÊàŦ»î¶¯ÒªÇóÏà¶ÔµÍ£¬ËùÒÔ»¼ÕßÒÀ´ÓÐԺᣵ«²¿ÃŲ¡ÀýÖÖÖ²µÄ΢Á£Æ¤³É»îÂʽϵÍ£¬Ðè¶à´ÎÖÖÖ²£¬ÐÞ¸´Ê±¼ä½Ï³¤¡£
3£®ÌÖÂÛ
Ƥ·ô´´ÃæÐÞ¸´Ò»Ö±ÊÇҽѧ½çºã¾Ã¹Ø×¢µÄ¿ÎÌâ[3~5]¡£Ä¿Ç°¹úÄÚÍâѧÕß¶ÔÆ¤·ôÂýÐÔÀ£ÑñµÄÖÎÁƽøÐÐÁ˹㷺Ñо¿£¬¶àÊýÈÏΪÊÖÊõÊÇ¿ØÖƺ;ÀÕý²¡Òò»ù´¡ÉϵÄÒ»ÖÖÐÐÖ®ÓÐЧµÄÖÎÁÆÊֶΣ¬µ«ÓÉÓÚÂýÐÔÀ£Ññ»¼Õß´ó¶àͬʱºÏ²¢È«ÉíÐÔ¼²²¡£¬ÈçÌÇÄò²¡£¬ÖзçºóµÄÖ«Ìå̱»¾£¬¼¹×µ´´ÉËËùÖµĽØÌ±£¬ÑÏÖØÈ«ÉíÓªÑø²»Á¼µÈ£¬Ê¹´óÃæ»ýƤ·ôÒÆÖ²»òƤ°ê×ªÒÆµÈÊÖÊõ·½Ê½Êܵ½ºÜ´óÏÞÖÆ¡£·ÇÊÖÊõÖÎÁÆÒªÁì°üÂÞ£ºÖÐÒ½ÖÎÁÆ¡¢ÎïÀíÖÎÁÆ¡¢Ï¸°ûÒò×ÓÖÎÁÆ¡¢Æ¤·ô×éÖ¯¹¤³ÌʹÓᢹÇËè¼ä³äÖʸÉϸ°ûÖÎÁƵÈ£¬µ«¸÷×÷Õß±¨µÀµÄÁÆÐ§·×Æç¡£ÊªÈóÉÕÉ˸à¾ßÓÐìÉú¼¡¡¢»îѪ»¯ðöµÄ¹¦Ð§£¬ÔÚΪ´´ÃæÌṩÉúÀíʪÈó»·¾³µÄͬʱ£¬ÄÜʹ»µËÀ×éÖ¯ºÍ´úл²úÎïÎÞËðÉ˵ÄÓɱíÈëÀïµØÒº»¯¡¢Åųö£¬²Ð´æÆ¤·ô×éÖ¯Ïò¸Éϸ°ûÆ«Ïòת»¯£¬×îÖÕʵÏÖÆ¤·ôԭλÔÙÉúÓúºÏ[6]¡£¹úÍâѧÕßҲ֤ʵMEBO¶ÔƤ·ôÀ£ÑñÓÐÁ¼ºÃµÄÁÆÐ§[7]¡£ÂýÐÔÌå±íÀ£ÑñµÄÌØµãÊÇ´´ÔµÏËά×éÖ¯»·ÈÆ¡¢´´ÖÜÉÏÆ¤ÅÀÐÐÊÜÏÞ£»´´ÃæÈâÑ¿×éÖ¯Óë´´ÖÜÉÏÆ¤×éÖ¯¸ôÀ룻´´ÃæÈâÑ¿×éÖ¯ÀÏ»¯¡¢²Ô°×£¬ÎÞÆ¤·ô×éÖ¯²Ð´æ¡£Òò´ËÑî¹úÃ÷[2]¡¢Íõ¼Ì»¸[8]¡¢ºÎÈÊÁÁ£Û9£ÝµÈ½ÓÄÉMEBOÅàÑøÐÂÏÊÈâÑ¿ÔÙ×÷΢Á£Æ¤ÖÖÖ²ÖÎÁÆ¢ó¶ÈÉîÐÍÉÕÉË´´ÃæÈ¡µÃÁËÁ¼ºÃЧ¹û£¬ÎÒÃÇÀûÓÃMEBOÒ©¸à½áºÏ×ÔÌå΢Á£Æ¤ÖÖÖ²ÖÎÁÆÂýÐÔÆ¤·ôÀ£Ññ±íÃ÷£¬¸Ã¼¼Êõ²Ù×÷¼òµ¥£¬ÎÞÐèÌØÊâÊÖÊõÉ豸ºÍÕòÍ´ÒªÇó£»¾­ÅàÖ²µÄÐÂÉúƤÈáÈí£¬ÊàŦ¹¦Ð§»Ö¸´ºÃ£¬»¼ÕßÄÍÊÜÐԺã¬ÖÎÁÆÐ§¹ûÏÔÖø£¬ÓÈÆäÊÊÓÃÓÚ²»ÄܽÓÊÜ´óƬֲƤµÄ»¼Õß¡£
²Î ¿¼ ÎÄ Ï×
[1]Lamme EN£¬Van Leeuwen RT£¬Brandsma K£¬et al£®Higher numbers of autologous fibroblasts in an artificial substitute improve tissue regeneration and modulate scar tissue formation[J] £®J Pathol£¬2000£¬190£º595~603£®
[2] Ñî¹úÃ÷£¬ÕÔ¿¡Ï飬ӺÕþ£®MEBTÅäºÏÈâÑ¿´´ÃæÎ¢Á£Æ¤ÖÖÖ²ÖÎÁÆÉî¢ó¶ÈÉÕÉË[J] £®ÖйúÉÕÉË´´ÑñÔÓÖ¾£¬1998£¬34£¨1£©£º28~29£®
[3] Scott PG£¬Ghahary A£¬Tredget EE£®Molecular and cellular aspects of fibrosis following thermal injury[J] £®Hand Clin£®2000£¬16£º271~287£®
[4] ¸¶Ð¡±ø£¬ËïͬÖù£¬ÑîÒø»Ô£¬µÈ£®¼îÐÔ³ÉÏËάϸ°ûÉú³¤Òò×ÓºÍת»¯Éú³¤Òò×Ó-βÔÚÀ£ÑñÓëÔöÉúÐ԰̺Û×éÖ¯Öеıí´ï¼°Æä¶Ô´´ÉËÐÞ¸´µÄÓ°Ïì[J] £®ÖйúÐÞ¸´Öؽ¨Íâ¿ÆÔÓÖ¾£¬2000£¬14£º271~274£®
[5] Ñî´ºÃ÷£®¼±Ö¢Íâ¿ÆÑ§[M] £®µÚÒ»°æ£¬±±¾©£ºÈËÃñ¾üÒ½³öÊéÉ磬2001£º162~164£®
[6] ÐìÈÙÏ飬ÐíÔö»£®ÉÕÉËʪÐÔÒ½ÁƼ¼Êõ¶Ô±íƤÔÙÉú¸Éϸ°û×÷ÓõÄÑо¿[J] £®ÖйúÉÕÉË´´ÑñÔÓÖ¾£¬2000£¬3£º41~42£®
[7] Atiyeh BS£¬ Ioannovich J£¬ Magliacani G£¬ Masellis M£¬ Costagliola M£¬ Dham R£®The efficacy of MEBO £¨moist exposed burn ointment£© in the management of cutaneous wounds and ulcers£º a pilot study[J] £®Letter-to-the-editor£¬ Ann Plast Surg 2002£¬48£º 226~227£®
[8] Íõ¼Ì»¸£¬ÕŲÊϼ£®MEBOÖÎÁÆÍç¹ÌÐÔÂýÐÔÀ£Ññ168Àý[J] £®ÖйúÉÕÉË´´ÑñÔÓÖ¾£¬1998£¬34£¨4£©£º36~37£®
[9] ºÎÈÊÁÁ£¬ÁõÓ¢Ï飬³ÂÓÀÁˆ£¬µÈ£®×ÔÌå΢Á£Æ¤ÖÖÖ²ÉÏÆ¤»¯ÔÙÉúÐÞ¸´´óÃæ»ýÉî¶ÈÉÕÉË´´Ãæ×é֯ѧÊÓ²ì[J] £®ÖйúÉÕÉË´´ÑñÔÓÖ¾£¬2007£¬19£¨1£©£º7~10£®
¡¾×÷Õß¼ò½é¡¿
ºÎÈÊÁÁ£¨1968~£©£¬ÄУ¨ºº×壩£¬ºþÄϰ²ÈÊÈË£¬ÄÏ·½Ò½¿Æ´óѧÔÚ¶Áҽѧ˶ʿ£¬Ö÷Òª´ÓÊÂÆ¤·ô¿Æ¡¢Æ¤·ô´´ÃæÐÞ¸´¡¢Æ¤·ôÍâ¿ÆÁÙ´²ºÍ¿ÆÑУ¬¿ÆÖ÷ÈΣ¬¸±Ö÷ÈÎҽʦ£®
ÓàÖ¾ºÍ£¨1971~£©£¬ÄУ¨ºº×壩£¬¹ã¶«ÖÐɽÈË£¬½áÒµÓÚÖÐɽ´óѧ£¬Ö÷Òª´ÓÊÂÍâ¿ÆÁÙ´²ºÍ¿ÆÑÐÒÔ¼°Ò½Ôº¹ÜÀí£¬¸±Ôº³¤£¬¸±Ö÷ÈÎҽʦ£®
ÁõÓ¢Ï飨1953~£©£¬ÄУ¨ºº×壩£¬¹ã¶«ÖÐɽÈË£¬½áÒµÓÚÖÐɽҽѧԺ£¬Ö÷Òª´ÓÊÂÍâ¿ÆÁÙ´²ºÍ¿ÆÑм°Ò½Ôº¹ÜÀí£¬Ôº³¤£¬¸±Ö÷ÈÎҽʦ£®

ÍøÕ¾µØÍ¼